Yesterday, Amneal Pharmaceuticals (AMRX) issued guidance for the first quarter of 2023 that came in over the consensus estimates. This sent shares trading as much as 14% higher in premarket trading. The stock opened Monday’s trading session at $1.34/share and closed at $1.63 for a nice single-day gain. The pharmaceutical company says that revenue [...]
This morning, UnitedHealth Group (UNH) reported first-quarter earnings that came in over expectations. The company doubled down on this success, raising the full-year outlook for 2023. And yet, shares of the company are falling - down nearly 3% in Friday’s trading session so far. This has investors and the market as a whole perplexed. [...]
Pfizer (PFE) has climbed more than 2% in this shortened trading week, and this could be due to the recent advancements in their latest vaccine. The RSV (respiratory syncytial virus) vaccine has been found to be 82% effective in preventing a respiratory virus in infants. The way the vaccine works is through administration to [...]
Elevance Health, Inc., (ELV:NYSE), founded in 1944 is based in Indianapolis. It is a health benefits provider that supports health at each life stage, providing health plans and clinical, behavioral, pharmacy, and complex-care solutions that promote members' whole health. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, [...]
Last week Moderna (MRNA) announced a licensing deal with Generation Bio that they hope will allow them to overcome the losses they’re facing now that the COVID-19 pandemic has come and gone. And as a result of this deal, Generation Bio (GBIO) gained 34% in the past week of trading. The partnership will have [...]
Monday morning’s trading session was not a pleasant one for DexCom (DXCM) or its investors. Shares of the medical device manufacturing company fell 8% by 12PM EST with no signs of slowing down. But what happened to cause this slip? It wasn’t necessarily anything DexCom did or didn’t do. Rather, close competitor Abbott Laboratories [...]
Last week, the stock market had its worst week in 2023 down about 2-3% depending upon the index selected, but Lantheus Holdings, Inc. (Nasdaq:LNTH) stock price jumped 21.3%. That was because its worldwide revenues for the fourth quarter and full year 2022, accelerated 103.1% and 119.9%, respectively, over prior year periods. Although not a [...]
As Pfizer’s sales continue to struggle, they’ve turned to acquisitions as a means of making up for lost revenue. And one company they have their eye on is Seagen - a cancer drugmaker with a market cap of roughly $30 billion. Last year, Seagen was rumored to be acquired by Merck. This deal could [...]
Catalent (CTLT) is all over the headlines this Monday morning as rumors surge of an acquisition. The buyer in question is Danaher (DHR), a company that designs and manufactures diagnostic tools for health, food, and water services. This play is said to be Danaher’s way of competing with Thermo Fisher Scientific. This marriage makes [...]
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was founded in 2003 and is incorporated and headquartered in Dublin, Ireland. JAZZ is a fully integrated, global biopharmaceutical company whose stated purpose is to provide innovative solutions and life-changing drugs to transform the lives of patients and their families across the globe, and result in longer lives. The [...]
